Searched for
PANACEA BIOTEC STOCK
Panacea Biotec shares rally 5% as co gets UNICEF supply order worth Rs 127 crorePanacea Biotec's shares rose 5% as the company received a Letter of Award from UNICEF for supplying 115 million doses of its bivalent oral ...- Dispute with Sanofi settled, Panacea scrip soars to over 3-yr highPanacea Biotec has settled a patent dispute with Sanofi Healthcare India, leading to a rise in its stock. The Delhi High Court case involve...
- Panacea Biotec zooms 20% on Rs 1,040-crore order win from UNICEF and PAHOPentavalent vaccine protects children against five deadly diseases: Diphtheria, Tetanus, Pertussis, Hepatitis B and invasive infections cau...
- Panacea Biotec founder and chairman Soshil Kumar Jain passes awayAs per a regulatory filing by the company, Jain , who had been admitted to the Medanta Hospital for the last ten days, died after suffering...
- Panacea Biotec hits 5% upper circuit after Mankind Pharma dealAs part of this arrangement, Mankind Pharma is retaining Panacea's sales and marketing team engaged in the particular business.
- Adar Poonawalla transfers entire Panacea Biotec stake worth Rs 118 cr to Serum InstitutePoonawalla sold 3.15 million shares of Panacea Biotech at Rs 373.85 per share to Serum Institute in a block deal on the BSE earlier today.
- Panacea Biotec soars 17% after company signs deal to produce Sputnik V vaccine dosesProduction of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF, a joint ...
- Panacea Biotec enters collaboration with Bionpharma for generics worth $800 millionShare prices spiked upon the development, going as high as 9.75% (Rs 148 a piece) on the Bombay Stock Exchange before 11:00 am on Friday.
- Serum Institute buys 3 lakh shares of Panacea for Rs 3.7 crVaccine firm Serum Institute of India today purchased about three lakh shares of Panacea Biotec for Rs 3.71 crore through open market trans...
- Panacea Biotec Q1 net dips 48.63 pc to Rs 16.72 crPanacea Biotec today said its net profit declined by 48.63 per cent to Rs 16.72 crore for the quarter ended June 30, 2011 over the same per...
- Panacea Biotec Q4 net dips 25.19% to Rs 43.03 crPanacea Biotec Ltd today said its net profit has declined by 25.19% to Rs 43.03 crore for the fourth quarter ended March 31, 2011.
- Laboratorios to market Panacea drug in EuropePanacea Biotec has signed a non-exclusive marketing agreement with Uruguay's Laboratorios Clausen SA, allowing the Latin American firm to m...
- Panacea Biotec Q3 net up over five-fold to Rs 42.60 crPanacea Biotec today said its net profit zoomed over five-fold to Rs 42.60 crore for the third quarter ended December 31, 2010, over the sa...
- Panacea Biotec Q3 net up nearly six fold to Rs 42.6 crThe company had posted a net profit of Rs 7.34 crore for the same quarter previous fiscal, Panacea Biotec said in a filing to the Bombay St...
- Panacea Biotec completes share buy-backDrug maker Panacea Biotec on Monday said it has closed its share buy-back offer with an outgo of Rs 109.82 crore.
- Panacea June quarter net profit zooms two-fold to Rs 32 crDrug-maker Panacea Biotec on Tuesday said net profit surged over two-fold to Rs 32.55 crore for the quarter ended June 30.
- Panacea Biotec is range bound: Sandeep Wagle, APTART Technical Advisory ServicesSandeep Wagle, Founder & MD, APTART Technical Advisory Services, in a chat with ET Now talks about Panacea Biotec.
- Serum Institute hikes stake in Panacea Biotec to 7%India’s largest vaccine maker, Serum Institute of India, has picked up close to 7% stake in rival firm Panacea Biotec.
- Panacea to buy 19.9% in PharmAthene for $13.1 mnVaccine maker Panacea Biotec has agreed to buy 19.9% in US-based PharmAthene for $13.1 mn.
- Panacea Biotec signs MoU with Panjab UniversityPanacea Biotec today said it has entered into an agreement with Panjab University to carry out research activities related to drug discover...
Load More
